These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18358571)

  • 1. Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps.
    German N; Wei P; Kaatz GW; Kerns RJ
    Eur J Med Chem; 2008 Nov; 43(11):2453-63. PubMed ID: 18358571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
    Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
    J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
    Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
    Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance.
    Sabatini S; Gosetto F; Iraci N; Barreca ML; Massari S; Sancineto L; Manfroni G; Tabarrini O; Dimovska M; Kaatz GW; Cecchetti V
    J Med Chem; 2013 Jun; 56(12):4975-89. PubMed ID: 23710549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
    Couto I; Costa SS; Viveiros M; Martins M; Amaral L
    J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efflux-mediated antibiotics resistance in bacteria].
    Cattoir V
    Pathol Biol (Paris); 2004 Dec; 52(10):607-16. PubMed ID: 15596311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From 6-aminoquinolone antibacterials to 6-amino-7-thiopyranopyridinylquinolone ethyl esters as inhibitors of Staphylococcus aureus multidrug efflux pumps.
    Pieroni M; Dimovska M; Brincat JP; Sabatini S; Carosati E; Massari S; Kaatz GW; Fravolini A
    J Med Chem; 2010 Jun; 53(11):4466-80. PubMed ID: 20446747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
    Rieg S; Huth A; Kalbacher H; Kern WV
    Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors.
    Samosorn S; Bremner JB; Ball A; Lewis K
    Bioorg Med Chem; 2006 Feb; 14(3):857-65. PubMed ID: 16203150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial efflux pump inhibition.
    Kaatz GW
    Curr Opin Investig Drugs; 2005 Feb; 6(2):191-8. PubMed ID: 15751743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
    Sangwan PL; Koul JL; Koul S; Reddy MV; Thota N; Khan IA; Kumar A; Kalia NP; Qazi GN
    Bioorg Med Chem; 2008 Nov; 16(22):9847-57. PubMed ID: 18848780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citral derived amides as potent bacterial NorA efflux pump inhibitors.
    Thota N; Koul S; Reddy MV; Sangwan PL; Khan IA; Kumar A; Raja AF; Andotra SS; Qazi GN
    Bioorg Med Chem; 2008 Jul; 16(13):6535-43. PubMed ID: 18524600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.
    Fontaine F; Héquet A; Voisin-Chiret AS; Bouillon A; Lesnard A; Cresteil T; Jolivalt C; Rault S
    Eur J Med Chem; 2015 May; 95():185-98. PubMed ID: 25817769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance].
    Doléans-Jordheim A; Michalet S; Bergeron E; Boisset S; Souard F; Dumontet C; Dijoux-Franca MG; Freney J
    Ann Biol Clin (Paris); 2008; 66(5):499-508. PubMed ID: 18957338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of bacterial efflux pumps: a new strategy to combat increasing antimicrobial agent resistance.
    Kaatz GW
    Expert Opin Emerg Drugs; 2002 Oct; 7(2):223-33. PubMed ID: 15989546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.
    Sabatini S; Gosetto F; Manfroni G; Tabarrini O; Kaatz GW; Patel D; Cecchetti V
    J Med Chem; 2011 Aug; 54(16):5722-36. PubMed ID: 21751791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of new arylbenzo[b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
    Fournier Dit Chabert J; Marquez B; Neville L; Joucla L; Broussous S; Bouhours P; David E; Pellet-Rostaing S; Marquet B; Moreau N; Lemaire M
    Bioorg Med Chem; 2007 Jul; 15(13):4482-97. PubMed ID: 17498961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of 2-mercapto-1,3-benzothiazole derivatives with potential antimicrobial activity.
    Franchini C; Muraglia M; Corbo F; Florio MA; Di Mola A; Rosato A; Matucci R; Nesi M; van Bambeke F; Vitali C
    Arch Pharm (Weinheim); 2009 Oct; 342(10):605-13. PubMed ID: 19753564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperazinyl-linked fluoroquinolone dimers possessing potent antibacterial activity against drug-resistant strains of Staphylococcus aureus.
    Kerns RJ; Rybak MJ; Kaatz GW; Vaka F; Cha R; Grucz RG; Diwadkar VU; Ward TD
    Bioorg Med Chem Lett; 2003 May; 13(10):1745-9. PubMed ID: 12729656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.